Otsuka Pharmaceutical Development & Commercialization, Inc.

Form 483

Princeton, New Jersey, United StatesFEI 3010447004Issued March 18, 2014

View FDA's Record for This Firm

Source: FDA inspection record. Confirmed against FDA's published inspection data for this establishment and inspection date. FDA has published the inspection and what it cited, but not the form itself, which usually takes six to twelve months. To check it, open FDA's record for this establishment on FDA's Data Dashboard, listed under FEI 3010447004.

Observations2

Issue DateMarch 18, 2014

StatusNo Warning Letter

Related Inspections3

Establishment Details

Firm: Otsuka Pharmaceutical Development & Commercialization, Inc.
Location: Princeton, New Jersey, United States
FEI Number: 3010447004
Product Type: Drugs
Issue Date: March 18, 2014
Country: United States

Inspection History, 2014 to 2025

NAI2

VAI1

NAI means No Action Indicated. VAI means Voluntary Action Indicated.

Act on This Form 483

FDA Inspection ReadinessSee how your operations would hold up to the same scrutiny.CAPA & InvestigationsScore how you would investigate and close findings like these.Talk to a SpecialistWalk through these observations with a ComplianceQuest expert.

Otsuka Pharmaceutical Development & Commercialization, Inc. FDA Form 483, Princeton, New Jersey, March 18, 2014